NCT05752305View on ClinicalTrials.gov

Use of Corticosteroids in Third Molar Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 15, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

July 15, 2023

Conditions
InflammationPain, PostoperativeTrismus
Interventions
DRUG

Dexamethasone 4 Mg/mL Injectable Solution

Preoperative submucosal administration of 8mg of dexamethasone or 40mg of methylprednisolone.

DRUG

MethylPREDNISolone 40 Mg/mL Injectable Suspension

Preoperative submucosal administration of 8mg of dexamethasone or 40mg of methylprednisolone.

Trial Locations (1)

Unknown

Unai Fernández Martín, Granada

All Listed Sponsors
lead

Universidad de Granada

OTHER